Morgan Stanley lowers Pfizer (NYSE:PFE) price target from $39 to $37

By / / Pfizer

Morgan Stanley analyst Terence Flynn maintains Pfizer (NYSE:PFE) with a Equal-Weight and lowers the price target from $39 to $37.

Scroll to Top